UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatitis C screening and detection program in a large population: Epidemiological transition and characterization of the disease

Liver international, 2023-06, Vol.43 (6), p.1225-1233

2023

Volltextzugriff (PDF)

Alcohol-related liver disease: A global perspective

Annals of hepatology, 2024-09, Vol.29 (5), p.101499, Article 101499

2024

Volltextzugriff (PDF)

Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study

Hepatology international, 2020-09, Vol.14 (5), p.817-827

2020

Volltextzugriff (PDF)

S3275 Metric Differences in Anatomy and Esophageal Pressure Profiles of the Initial Basal Period vs the Final Basal Period in High-Resolution Manometry, Preliminary Report

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S1349-S1349

2021

Volltextzugriff (PDF)

Interaction of metabolic dysfunction‐associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019

Hepatology communications, 2022-08, Vol.6 (8), p.2000-2010

2022

Volltextzugriff (PDF)

An Integrated Review of the Hepatorenal Syndrome

Annals of hepatology, 2021-05, Vol.22, p.100236-100236, Article 100236

2021

Volltextzugriff (PDF)

H3K9me3 demethylation by JMJD2B is regulated by pirfenidone resulting in improved NASH

Scientific reports, 2024-10, Vol.14 (1), p.24714-14, Article 24714

2024

Volltextzugriff (PDF)

OP-4 IMPLEMENTATION OF A RE-LINKAGE TO CARE STRATEGY IN PATIENTS WITH CHRONIC HEPATITIS C WHO WERE LOST TO FOLLOW-UP IN LATIN AMERICA

Annals of hepatology, 2023-03, Vol.28, p.101053, Article 101053

2023

Volltextzugriff (PDF)

NRF-2 and nonalcoholic fatty liver disease

Annals of hepatology, 2020-09, Vol.19 (5), p.458-465

2020

Volltextzugriff (PDF)

Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study

Annals of hepatology, 2021-09, Vol.24, p.100338-100338, Article 100338

2021

Volltextzugriff (PDF)

Reply to: Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico

Annals of hepatology, 2021-09, Vol.24, p.100354-100354, Article 100354

2021

Volltextzugriff (PDF)

Survival of patients with hepatocellular carcinoma treated with immunotherapy experience of a third level center

Annals of hepatology, 2024-02, Vol.29, p.101428, Article 101428

2024

Volltextzugriff (PDF)

Autoimmune biomarkers in porto‐sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology

Liver international, 2021-09, Vol.41 (9), p.2171-2178

2021

Volltextzugriff (PDF)

Drug‐Induced Liver Injury: A Mexican View

Clinical liver disease (Malden, Mass.), 2022-02, Vol.19 (2), p.78-81

2022

Volltextzugriff (PDF)

Evaluation of the ALBI, MELD, MELD-Na, MELD 3.0 score in patients with hepatocellular carcinoma treated with Yttrium-90 (90y)

Annals of hepatology, 2024-02, Vol.29, p.101440, Article 101440

2024

Volltextzugriff (PDF)

P- 77 EPIGENOME OF PATIENTS WITH LIVER FIBROSIS, WITH SUSTAINED VIRAL RESPONSE TO HCV IN LIVER BIOPSY AND LIQUID BIOPSY REVEALS THE ASSOCIATION OF DNA METHYLATION AND miRNA EXPRESSION WITH THE DEGREE OF SEVERITY

Annals of hepatology, 2023-03, Vol.28, p.100972, Article 100972

2023

Volltextzugriff (PDF)

Impacto de COVID-19 en enfermedad hepatica pre-existente

Cirugia y cirujanos, 2024-03, Vol.92 (1)

2024

Volltextzugriff (PDF)

P-4 ALBUMIN LEVELS HAVE STRONGASSOCIATION WITH MORTALITY IN COVID-19 INFECTED PATIENS

Annals of hepatology, 2021-09, Vol.24, p.100370-100370, Article 100370

2021

Volltextzugriff (PDF)

AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis

Cells (Basel, Switzerland), 2023-08, Vol.12 (17), p.2127

2023

Volltextzugriff (PDF)

P-37 EXPERIENCE IN MEXICO WITH DIRECT ACTING ANTIVIRALS AS A TREATMENT FOR HEPATITIS C

Annals of hepatology, 2021-09, Vol.24, p.100401, Article 100401

2021

Volltextzugriff (PDF)

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Hepatology (Baltimore, Md.), 2023-12, Vol.78 (6), p.1966-1986

2023

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(59)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Hepatology
(18)
Journal Of Hepatology
(8)
Cirugía Y Cirujanos
(3)
Hepatology
(3)
Liver International
(3)
Cirugia Y Cirujanos
(2)
Gastroenterology
(2)
Revista De Sanidad Militar
(2)
American Journal Of Internal Medicine
(1)
Antioxidants
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hepatitis C screening and detection program in a large population: Epidemiological transition and characterization of the disease

Alcohol-related liver disease: A global perspective

Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study

S3275 Metric Differences in Anatomy and Esophageal Pressure Profiles of the Initial Basal Period vs the Final Basal Period in High-Resolution Manometry, Preliminary Report

Interaction of metabolic dysfunction‐associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019

An Integrated Review of the Hepatorenal Syndrome

H3K9me3 demethylation by JMJD2B is regulated by pirfenidone resulting in improved NASH

OP-4 IMPLEMENTATION OF A RE-LINKAGE TO CARE STRATEGY IN PATIENTS WITH CHRONIC HEPATITIS C WHO WERE LOST TO FOLLOW-UP IN LATIN AMERICA

NRF-2 and nonalcoholic fatty liver disease

Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study

Reply to: Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico

Survival of patients with hepatocellular carcinoma treated with immunotherapy experience of a third level center

Autoimmune biomarkers in porto‐sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology

O-17 Are macroeconomic and health expenditure indicators correlated with the capacity for liver transplantation in Latin American Countries? THE ALEH Special Interest Group, international Survey 2020

O-3 TRENDS IN DECEASED DONOR AND LIVING DONOR LIVER TRANSPLANTATION IN LATIN AMERICAN COUNTRIES DURING A DECADE (2010-2019) . THE ALEH SPECIAL INTEREST GROUP, INTERNATIONAL SURVEY 2020

OP-4 Current status of Liver transplantation in Latin America: The Latin-American ALEH special interest group, international Survey 2020

Drug‐Induced Liver Injury: A Mexican View

Evaluation of the ALBI, MELD, MELD-Na, MELD 3.0 score in patients with hepatocellular carcinoma treated with Yttrium-90 (90y)

P- 77 EPIGENOME OF PATIENTS WITH LIVER FIBROSIS, WITH SUSTAINED VIRAL RESPONSE TO HCV IN LIVER BIOPSY AND LIQUID BIOPSY REVEALS THE ASSOCIATION OF DNA METHYLATION AND miRNA EXPRESSION WITH THE DEGREE OF SEVERITY

Impacto de COVID-19 en enfermedad hepatica pre-existente

P-4 ALBUMIN LEVELS HAVE STRONGASSOCIATION WITH MORTALITY IN COVID-19 INFECTED PATIENS

AdhMMP8 Vector Administration in Muscle: An Alternate Strategy to Regress Hepatic Fibrosis

P-37 EXPERIENCE IN MEXICO WITH DIRECT ACTING ANTIVIRALS AS A TREATMENT FOR HEPATITIS C

A Novel Foodstuff Mixture Improves the Gut-Liver Axis in MASLD Mice and the Gut Microbiota in Overweight/Obese Patients

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Suchergebnisse filtern